Zobrazeno 61 - 70
of 1 203
pro vyhledávání: ''
Autor:
Oumar Camara, Carola Rabenstein, Cornelia Jörke, Klaus Hoeffken, Ingo B. Runnebaum, Katharina Pachmann, Anne Egbe, U. Hammer
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 135(4):643-647
In breast cancers, the gene for the growth factor receptor HER2 can be amplified leading to increased aggressiveness and metastasis formation. The monoclonal antibody trastuzumab prolongs relapse-free survival highly significantly but eventually many
Autor:
Tianfeng Wang, Ai-ping Lu, Yiqiang Liu, Yijun Zhou, Zhaoqing Fan, Tao Ouyang, Yuntao Xie, Jinfeng Li, Yingjian He
Publikováno v:
Breast Cancer Research and Treatment
This study aimed to compare the efficacy and safety aspects of three anthracycline-based regimens as neoadjuvant chemotherapy in primary breast cancer. Five-hundred and one patients with clinical stage I-III invasive breast cancer were randomly assig
Autor:
Toru Watanabe
Publikováno v:
Breast Cancer (Tokyo, Japan)
Oral fluoropyrimidine anticancer agents (oral 5-fluorouracil [5-FU]) able to be used as chemotherapy for breast cancer include tegafur–uracil (UFT), tegafur–gimeracil–oteracil potassium (S-1), doxifluridine, and capecitabine. Since the 1980s, U
Publikováno v:
Current Breast Cancer Reports
Oncoplastic surgery is integral to all breast cancer surgeries. The use of an aesthetic approach to breast conservation or mastectomy greatly enhances the range of options that can be offered to women with breast cancer and facilitates better outomes
Autor:
Rossana Bossi, Jørn Olsen, Manhai Long, Eva Cecilie Bonefeld-Jørgensen, Stine Overvad Fredslund
Publikováno v:
Cancer Causes & Control
Bonefeld-Jørgensen, E C, Long, M, Fredslund, S O, Bossi, R & Olsen, J 2014, ' Breast cancer risk after exposure to perfluorinated compounds in Danish women : a case-control study nested in the Danish National Birth Cohort ', Cancer causes & control : CCC, vol. 25, no. 11, pp. 1439-1448 . https://doi.org/10.1007/s10552-014-0446-7
Bonefeld-Jørgensen, E C, Long, M, Fredslund, S O, Bossi, R & Olsen, J 2014, ' Breast cancer risk after exposure to perfluorinated compounds in Danish women : a case-control study nested in the Danish National Birth Cohort ', Cancer causes & control : CCC, vol. 25, no. 11, pp. 1439-1448 . https://doi.org/10.1007/s10552-014-0446-7
Objective Animal studies have indicated that perfluoroalkylated substances (PFAS) increase mammary fibroadenomas. A recent case–control study in Greenlandic Inuit women showed an association between the PFAS serum levels and breast cancer (BC) risk
Autor:
M E, Cazzaniga, L, Cortesi, A, Ferzi, L, Scaltriti, F, Cicchiello, M, Ciccarese, S, Della Torre, F, Villa, M, Giordano, C, Verusio, M, Nicolini, A R, Gambaro, L, Zanlorenzi, E, Biraghi, L, Legramandi, E, Rulli, Valter, Torri
Publikováno v:
Breast Cancer Research and Treatment
Purpose: The VICTOR-1 study demonstrated that the all-oral metronomic combination of vinorelbine and capecitabine is highly active and well tolerated in hormone receptor-positive/HER2-negative patients. The VICTOR-2 study was designed to confirm thes
Autor:
Stephen B. Edge, John E. Vena, Jan Beyea, Paola Muti, Matthew R. Bonner, Jing Nie, Jo L. Freudenheim, Daikwon Han, Dominica Vito, Maurizio Trevisan, Peter A. Rogerson
Publikováno v:
Cancer Causes & Control. 18(9):947-955
We previously reported that total suspended particulates exposure (a measure of air pollution) at the time of birth was related to increased postmenopausal breast cancer risk. In this study, we examined breast cancer risk in relation to exposure to a
Autor:
Ulrich Bick, Felix Diekmann
Publikováno v:
European Radiology. 17(8):1931-1942
High-quality full-field digital mammography has been available now for several years and is increasingly used for both diagnostic and screening mammography. A number of different detector technologies exist, which all have their specific advantages a
Autor:
Jan Steffen, Michalina Dabrowska, Aneta Balabas, Magdalena Piatkowska, Dorota Nowakowska, Izabela Brozek, Anna Niwińska, Magdalena Ratajska, Jadwiga Rachtan, Janusz Limon, Anna Kluska
Publikováno v:
Familial Cancer
It is estimated that about 5–10% of ovarian and 2–5% of all breast cancer patients are carriers of a germline BRCA1 or BRCA2 gene mutation. Most families with detected BRCA1 or BRCA2 gene mutation are qualified for molecular testing on the basis
Autor:
Tse Jia Liu, Nam Sun Paik, Zhen Zhou Shen, Hiram S. Cody, Stanley P. L. Leong, Tomoo Tajima, Kerstin Sandelin, William D. Foulkes, Gaurav Agarwal, Anna M. Derossis
Publikováno v:
World Journal of Surgery
A mini-symposium was held in Montreal, Canada, at the International Surgical Week for the Breast Surgical International in 2007 addressing the question whether breast cancer is the same disease in Asian and Western countries. Numerous investigators f